BTL Industries, one of the largest manufacturers of medical devices in Malaysia’s healthcare system, unveiled its new range of medical innovations and devices for the Malaysian healthcare system. The event featured SUPER INDUCTIVE SYSTEM DUO (SIS DUO), BTL Walk, R-Force, BTL EXO, BTL CardioPoint, and the latest mental health device EXOMIND. The latest portfolio of technologies spans rehabilitation, mobility, and cardiac care, underscoring its role in driving innovation in non-invasive and technology-enabled therapy solutions.
Held in conjunction with Hari Raya Aidilfitri, the open house brought together healthcare professionals and industry partners, and was graced by.
The open house provided a platform for BTL Industries to highlight its continued commitment to advancing healthcare delivery through integrated technologies designed to improve patient outcomes, enhance clinical efficiency, and support more accessible and effective care pathways.
Supporting Physical Recovery and Heart Health
BTL Industries also showcased a range of technologies supporting physical rehabilitation and mobility recovery, highlighting its focus on modern approaches to restoring movement and function. These included:
- BTL SIS DUO: a non-invasive physiotherapy system using high-intensity electromagnetic fields to stimulate muscles, relieve pain, and support recovery
- BTL Walk: a robotic gait training system designed to assist patients in regaining mobility through guided, intelligent movement
- BTL Rforce: a zero-gravity treadmill that reduces body weight impact to enable safer rehabilitation
- BTL EXO: a robotic exoskeleton that supports patients with mobility impairments in standing, walking, and regaining independence
BTL also presented CardioPoint as an integrated diagnostic platform that streamlines multiple cardiac assessments with smart AI-assisted suggestions, alongside the BTL Cardiac Rehab system, which supports structured recovery programmes aimed at improving long-term cardiovascular health.
Expanding into Mental Health Treatment
A key highlight of the event was the unveiling of BTL EXOMIND, a ground-breaking mental wellness therapy, signalling BTL Industries’ growing focus on addressing both physical and mental health through advanced medical technology.
“Mental health is an area that requires greater attention and more accessible treatment options, particularly as more people come forward to seek help,” said Ms Mages Moganan, Director of BTL Industries Malaysia.
“With EXOMIND, we are introducing a clinically supported, non-invasive option that can complement existing treatment pathways. Early responses from users have been positive, with encouraging feedback on their experience with the system and that further motivates us to introduce this technology to the Malaysian market to broaden access to innovative, non-invasive approaches in mental healthcare.”
EXOMIND’s patented ExoTMS™ technology is patented in the US and comfortably stimulates key brain regions involved in emotional regulation, cognitive function, and self-control. The device works by activating neural pathways to support the treatment of depression and obsessive-compulsive disorder, as part of a comprehensive care plan guided by a qualified healthcare professional.
Advancing the Future of Therapy and Patient Care
The technologies showcased reflect BTL Industries broader aspiration to redefine modern therapy through non-invasive, intelligent, and patient-centric solutions. By integrating advanced robotics, electromagnetic therapy, neurostimulation, and digital diagnostics, the company aims to support clinicians in delivering more precise and efficient care while improving recovery outcomes for patients across different stages of treatment.
As healthcare systems continue to evolve, BTL Industries remains focused on expanding the role of technology in rehabilitation and therapy, with an emphasis on improving accessibility, enhancing treatment quality, and supporting long-term patient well-being.
